Home
Pfizer and BioNTech announced a vaccine against Covid-19 of 90 per cent efficacy from two injections three weeks apart. It was not known if it prevented transmission of the virus. The vaccine has to be stored at an ultra-low temperature of minus 80˚C. In July, the British government had bought 40 million doses, enough for a third of the population, with ten million available by the end of the year (along with access to five other vaccine candidates, totalling 340 million doses in all).
Already a subscriber? Log in
Subscribe for just $2 a week
Try a month of The Spectator Australia absolutely free and without commitment. Not only that but – if you choose to continue – you’ll pay just $2 a week for your first year.
- Unlimited access to spectator.com.au and app
- The weekly edition on the Spectator Australia app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Unlock this article
You might disagree with half of it, but you’ll enjoy reading all of it. Try your first month for free, then just $2 a week for the remainder of your first year.
Comments
Don't miss out
Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.
SUBSCRIBEAlready a subscriber? Log in